# A COMPARATIVE STUDY BETWEEN 1MG AND 3 MG OF GRANISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN STRABISMUS OPHTHALMIC SURGERIES DURING GENERAL ANESTHESIA

> **NCT04918862** · PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 210 (actual)

## Conditions studied

- 1mg Vs 3 mg of Granisetron

## Interventions

- **DRUG:** Granisetron

## Key facts

- **NCT ID:** NCT04918862
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-08
- **Primary completion:** 2021-05-09
- **Final completion:** 2021-05-18
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2021-06-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918862, "A COMPARATIVE STUDY BETWEEN 1MG AND 3 MG OF GRANISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN STRABISMUS OPHTHALMIC SURGERIES DURING GENERAL ANESTHESIA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04918862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*